SCHEMBL27270353

SCHEMBL27270353

COC(=O)C1OC(OC2C(O)C(CO)OC(C)C2NC(C)=O)C(OS(=O)(=O)O)C(O)C1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BMP2 P12643 3/20 0.39
▸ VEGFA P15692 3/20 0.39
▸ CXCL12 P48061 3/20 0.39
▸ SHH Q15465 2/20 0.39
▸ FGF1 P05230 2/20 0.39
▸ BDNF P23560 3/20 0.39
▸ PTN P21246 2/20 0.39
▸ MDK P21741 2/20 0.39
▸ CD69 Q07108 1/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ LGALS3 P17931 3/20 0.38
▸ F10 P00742 1/20 0.37
▸ LGALS8 O00214 1/20 0.37
▸ LGALS4 P56470 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ IFNG P01579 2/20 0.36
▸ CCL2 P13500 2/20 0.36
▸ PF4 P02776 1/20 0.36
▸ SELP P16109 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23336380 0.87 LGALS3 (0.48) CD69MAPK1LGALS3LGALS8LGALS4
SCHEMBL23336378 0.80 MDK (0.53) CXCL12BDNFPTNMDKCD69
SCHEMBL12214021 0.80 LGALS3 (0.45) CD69MAPK1LGALS3LGALS8LGALS4
SCHEMBL12213975 0.80 LGALS3 (0.45) CD69MAPK1LGALS3LGALS8LGALS4
SCHEMBL4544701 0.79 MAPK1 (0.44) BDNFPTNMDKCD69MAPK1
SCHEMBL12085239 0.79 MAPK1 (0.44) BDNFPTNMDKCD69MAPK1
SCHEMBL12213976 0.79 MAPK1 (0.44) BDNFPTNMDKCD69MAPK1
SCHEMBL25121361 0.79 MAPK1 (0.44) BDNFPTNMDKCD69MAPK1
SCHEMBL21374694 0.79 MAPK1 (0.44) BDNFPTNMDKCD69MAPK1
SCHEMBL18254178 0.79 MAPK1 (0.44) BDNFPTNMDKCD69MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240219372-A1 ANALYTICAL METHOD FOR GLYCOSAMINOGLYCANS JCR PHARMACEUTICALS CO., LTD. (JP) 2024-07-04 — — US disclosed
Send feedback